They can also add fullness to the lips and cheeks
Notably, weight loss had not plateaued at 52 weeks, suggesting potential for further reduction with continued treatment [44]
Continue rigorous glucose monitoring and medication adherence
Given the positive effects that GLP1 receptor agonists have on weight, significant interest exists in better understanding their potential role in managing osteoarthritis and associated pain
There are no legitimate long-term data to support it
Ann Neurol 68(2):145150 Smith JP, Bingaman SI, Ruggiero F, Mauger DT, Mukherjee A, McGovern CO, Zagon IS (2011) Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohns disease: a randomized placebo-controlled trial